Patent ID: 8592406
Filing Date: 2013-11-26
Classification: A61K,A61P,Y02A

Abstract:
1. An anticonvulsive pharmaceutical composition for transnasal administration, consisting essentially of: about 1% to about 20% by weight of a poorly soluble anticonvulsant, about 40% to about 60% by weight of diethylene glycol monoethyl ether, about 5% to about 30% by weight of methylpyrrolidone, about 1% to about 5% by weight of water, about 5% to about 10% by weight of alcohol, and fatty acid ester which is methyl laurate at about 5% to about 15% by weight of the pharmaceutical composition and/or propylene glycol monocaprylate at about 5% to about 25% by weight of the pharmaceutical composition.